Ischaemia modified albumin: a new biomarker for the diagnosis of venous thromboembolism? | Emergency Medicine Journal

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via RCEM

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via RCEM

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Abstracts for Venous Thromboembolism, Free Paper Session

Abstracts for Venous Thromboembolism, Free Paper Session, Thursday 17 September 10.30–11.15, Pippard Lecture Theatre

Ischaemia modified albumin: a new biomarker for the diagnosis of venous thromboembolism?

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Hinchliffe E, Haslam S, Sethi B, et al

Ischaemia modified albumin: a new biomarker for the diagnosis of venous thromboembolism?

Emergency Medicine Journal 2009;26:23.